VitriVax announces Series A financing to further demonstrate feasibility of its thermostable, single-dose vaccine technology, aiming to make life-saving biologics widely accessible to underserved populations globally

Redirecting to: https://www.prnewswire.com/news-releases/vitrivax-announces-series-a-financing-to-further-demonstrate-feasibility-of-its-thermostable-single-dose-vaccine-technology-aiming-to-make-life-saving-biologics-widely-accessible-to-underserved-populations-globally-301326705.html?tc=eml_cleartime

 

Connect With Us

          

 

Subscribe to E-Newsletter

  Subscribe

 

Support Innovation and Entrepreneurship

  Give Now